Screener
Evolent Health, Inc. EVH Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Evolent Health, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
FAQ
- What is Evolent Health, Inc.'s return on equity?
- Evolent Health, Inc. (EVH) reported return on equity of -79% in Q2 2026.
- How has Evolent Health, Inc.'s return on equity changed year-over-year?
- Evolent Health, Inc.'s return on equity decreased by 490.0% year-over-year, from -13.4% to -79%.
- What is the long-term trend for Evolent Health, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Evolent Health, Inc.'s return on equity has grown at a 11.8% compound annual growth rate (CAGR), from -43.3% to -75.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Evolent Health, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude